Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study.
Robert ChallenEllen Brooks-PollockJonathan M ReadLouise DysonKrasimira Tsaneva-AtanasovaLeon DanonPublished in: BMJ (Clinical research ed.) (2021)
The probability that the risk of mortality is increased by infection with VOC-202012/01 is high. If this finding is generalisable to other populations, infection with VOC-202012/1 has the potential to cause substantial additional mortality compared with previously circulating variants. Healthcare capacity planning and national and international control policies are all impacted by this finding, with increased mortality lending weight to the argument that further coordinated and stringent measures are justified to reduce deaths from SARS-CoV-2.
Keyphrases
- sars cov
- cardiovascular events
- healthcare
- risk factors
- end stage renal disease
- public health
- ejection fraction
- respiratory syndrome coronavirus
- chronic kidney disease
- gene expression
- body mass index
- cardiovascular disease
- prognostic factors
- type diabetes
- coronary artery disease
- copy number
- dna methylation
- weight loss
- risk assessment
- weight gain
- social media
- health information